Genmab — September 2019
-
Der skulle komme Esmo abstract om TV i nat ? https://www.esmo.org/Conferences/ESMO-Congress-2019/Abstracts
-
Anti-CD38 may enhance effector T-cell in CLL https://twitter.com/pilarnavaparada/status/1175850863803404290?s=21
-
God morgen. :-). KOL views results: Leading neurologist sees Ofatumumab growing antistof-CD20 class and eating lnto Ocrevus' growt. ( FirstWord). https://m.firstwordpharma.com/benefits
-
God morgen.

-
De er ikke helt enige over-there ;-). https://medwatch.dk/Medicinal___Biotek/article11629882.ece
-
God morgen

-
Politikere verden over er kendt for at symptombehandle problemer i stedet for at løse dem. Du kan ikke implementere tvang i det frie marked der fungerer glimrende og i høj grad er selvregulerende. Deres problem i US er at de modsat DK ikke har offentlige ansatte specialister i de forskellige stater til at anbefale medicinen der skal benyttes. Tit fortsætter man med at bruge den dyre patentmedicin selvom den er udløbet. Kopimedicinen kan det samme og koster tit 1/10 af originalprisen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind
